Skip to main content

Table 2 Dentists’ awareness of MRONJ and protocol followed before dental procedures

From: The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

Variable N %
Do you record if the patient is taking anti-osteoporotic drugs?   
Yes 969 96.9
No 31 3.1
Do you record the name of the drug and duration of its use?   
No 187 18.7
Name only 163 16.3
Name and duration 650 65.0
Do you ask for a doctor's referral letter prior to dental surgery procedures?   
Yes 591 59.1
No 409 40.9
How long do you advise patients to discontinue the anti-osteoporotic agent before tooth extraction or implant placement?   
 ≤ 2 months 149 14.9
3–5 months 457 45.7
 ≥ 6 months 394 39.4
Do you recommend different drug holidays depending on the type of drug (bisphosphonates, denosumab, SERMs, PTH)?   
Yes 467 46.7
No 533 53.3
If you have encountered case/s of MRONJ, what type of medication caused it?   
Bisphosphonates 276 27.6
Denosumab 13 1.3
SERMs 4 0.4
No experience 707 70.7
  1. MRONJ, medication-related osteonecrosis of the jaw; SERMs, selective estrogen-receptor modulators; PTH, parathyroid hormone